4.7 Article

Fusobacterium nucleatum secretes amyloid-like FadA to enhance pathogenicity

期刊

EMBO REPORTS
卷 22, 期 7, 页码 -

出版社

WILEY
DOI: 10.15252/embr.202152891

关键词

amyloid; colorectal cancer; Fusobacterium nucleatum; FadA; periodontal disease

资金

  1. NIH [R01CA192111, R01DE029532, R35 GM124633-01]
  2. Irma T. Hirschl Career Scientist Award [R01AI132403]
  3. Burroughs Wellcome Fund [PATH1016691, R01AR065564, 1S10OD025102]
  4. China Scholarship Council [201806790025]

向作者/读者索取更多资源

Fusobacterium nucleatum secretes an adhesin with amyloid properties to enhance virulence, inducing periodontal bone loss and promoting colorectal cancer progression in mice. Virulence can be attenuated by amyloid-binding compounds.
Fusobacterium nucleatum (Fn) is a Gram-negative oral commensal, prevalent in various human diseases. It is unknown how this common commensal converts to a rampant pathogen. We report that Fn secretes an adhesin (FadA) with amyloid properties via a Fap2-like autotransporter to enhance its virulence. The extracellular FadA binds Congo Red, Thioflavin-T, and antibodies raised against human amyloid beta 42. Fn produces amyloid-like FadA under stress and disease conditions, but not in healthy sites or tissues. It functions as a scaffold for biofilm formation, confers acid tolerance, and mediates Fn binding to host cells. Furthermore, amyloid-like FadA induces periodontal bone loss and promotes CRC progression in mice, with virulence attenuated by amyloid-binding compounds. The uncleaved signal peptide of FadA is required for the formation and stability of mature amyloid FadA fibrils. We propose a model in which hydrophobic signal peptides serve as hooks to crosslink neighboring FadA filaments to form a stable amyloid-like structure. Our study provides a potential mechanistic link between periodontal disease and CRC and suggests anti-amyloid therapies as possible interventions for Fn-mediated disease processes.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据